Novel Functions of the Ah Receptor
Novel Functions of the Ah Receptor
批准号:
6856536
负责人:
JOHN J REINERS
金额:
$29.8万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
1999
资助国家:
美国
项目状态:
已结题
起止时间:
1999-02-01 至 2007-02-28
关键词:
animal genetic material tagapoptosisaromatic hydrocarbon receptorceramidescysteine endopeptidasesenzyme activityfibroblastsgenetically modified animalsglycosylationhepatocellular carcinomaintermolecular interactionlaboratory mouseliver cellsmutantprotein structure functionspleentissue /cell culturetranscription factortransport proteins
中文摘要
点击翻译按钮获取中文摘要
英文摘要
EXCEED THE SPACE PROVIDED. The biological functions of the aryl hydrocarbon receptor (AhR) are normallyattributed to its functioning as a ligand-activated transcription factor. However, recent studies suggest that the AhR may have ligand- independent functions. Studies with murine hepatoma cells engineered to have different AhR contents show a direct correlation between AhR content and susceptibility to apoptosis induced by ceramide, but not other agents. Recent studies have shown that ceramide causes lysosome disruption, cleavage of cytosolic Bid, release of cytochrome c, and activation of the 'mitochondria!'apoptotic pathway in AhR-containing cells. The effects of ceramide could be duplicated by the targeted disruption of lysosomes with photodynamic therapy (PDT). Because PDT and ceramide disrupt the lysosomes of AhR-deficient cells, but do not cause Bid cleavage we hypothesize that 1) lysosome disruption triggers the 'mitochondria!' apoptotic pathway via lysosomal protease cleavage of Bid, and 2) the AhR modulates processes involved in Bid cleavage. In this application we propose to use Bid null and AhR null cells to determine if activation of the 'mitochondria!' apoptotic pathway by ceramide/PDTis dependent upon 1) Bid and 2) AhR content, respectively. 3) We will determine if the inability of our AhR-deficient cell lines to cleave Bid reflects the absence of a lysosomal Bid cleavage activity, or the presence of cytosolic protein(s) that inhibit this activity. 4) We will attempt to identify the lysosomal activity responsible for Bid cleavage by conventional purification techniques, selective pharmacological inhibition, or a proteomic approach. 5) Transfection of mutated forms of the AhR into AhR-deficient cells will be used to determine the regions/functions (e.g., DNA and ligand-binding, heterodimerization, transactivation, etc.) of the AhR important in the modulation of Bid cleavage/ceramide- induced apoptosis. Lastly, 6) a series of 'oxidative stressors' will be tested to determine if oxidant-induced activation of the 'mitochondria!' apoptotic pathway is a downstream consequence of lysosome disruption and Bid cleavage. These studies will provide a mechanism linking lysosome disruption and apoptosis, and characterize a novel AhR function. The concept that lysosome disruption can trigger apoptosis, in addition to necrosis, is relevant to the mechanism of action of many toxicants, and health-related areas such as neuro and pulmonary toxicology, chemo-and phototherapy, stroke research, and reperfusion induced injury. PERFORMANCE SITE ========================================Section End===========================================
期刊论文(3)
专著(0)
科研奖励(0)
会议论文
DOI:
--
发表时间:
2000
期刊:
Cancer research.
影响因子:
--
作者:
[Kessel,D, Caruso,JA, ReinersJr,JJ]
通讯作者:
ReinersJr,JJ
DOI:
10.1016/j.freeradbiomed.2010.11.006
发表时间:
2011-01-15
期刊:
FREE RADICAL BIOLOGY AND MEDICINE
影响因子:
7.4
作者:
[Reiners, John J., Jr., Kleinman, Miriam, Kessel, David, Mathieu, Patricia A., Caruso, Joseph A.]
通讯作者:
Caruso, Joseph A.
CORE--Cell Signaling Research Core
-
批准号:6750894
-
项目类别:
-
资助金额:$4.11万
-
财政年份:2004
-
负责人:JOHN J REINERS
-
依托单位:
Training Program in Molecular and Cellular Toxicology
-
批准号:6766910
-
项目类别:
-
资助金额:$6.41万
-
财政年份:2003
-
负责人:JOHN J REINERS
-
依托单位:
Training Program in Molecular and Cellular Toxicology
-
批准号:6593640
-
项目类别:
-
资助金额:$6.13万
-
财政年份:2003
-
负责人:JOHN J REINERS
-
依托单位:
Training Program in Molecular and Cellular Toxicology
-
批准号:7256244
-
项目类别:
-
资助金额:$5.91万
-
财政年份:2003
-
负责人:JOHN J REINERS
-
依托单位:
Training Program in Molecular and Cellular Toxicology
-
批准号:7088756
-
项目类别:
-
资助金额:$6.41万
-
财政年份:2003
-
负责人:JOHN J REINERS
-
依托单位:
Training Program in Molecular and Cellular Toxicology
-
批准号:6916452
-
项目类别:
-
资助金额:$6.31万
-
财政年份:2003
-
负责人:JOHN J REINERS
-
依托单位:
Training Program in Molecular and Cellular Toxicology
-
批准号:7649966
-
项目类别:
-
资助金额:$4.18万
-
财政年份:2003
-
负责人:JOHN J REINERS
-
依托单位:
RESEARCH CORE-- SIGNAL TRANSDUCTION
-
批准号:6597610
-
项目类别:
-
资助金额:$17.41万
-
财政年份:2002
-
负责人:JOHN J REINERS
-
依托单位:
RESEARCH CORE-- SIGNAL TRANSDUCTION
-
批准号:6446938
-
项目类别:
-
资助金额:$17.41万
-
财政年份:2001
-
负责人:JOHN J REINERS
-
依托单位:
RESEARCH CORE-- SIGNAL TRANSDUCTION
-
批准号:6301458
-
项目类别:
-
资助金额:$15.83万
-
财政年份:2000
-
负责人:JOHN J REINERS
-
依托单位:
RESEARCH CORE-- SIGNAL TRANSDUCTION
-
批准号:6347453
-
项目类别:
-
资助金额:$17.41万
-
财政年份:2000
-
负责人:JOHN J REINERS
-
依托单位:
NOVEL FUNCTIONS OF THE AH RECEPTOR
-
批准号:2766105
-
项目类别:
-
资助金额:$24.4万
-
财政年份:1999
-
负责人:JOHN J REINERS
-
依托单位:
NOVEL FUNCTIONS OF THE AH RECEPTOR
-
批准号:6350823
-
项目类别:
-
资助金额:$25.74万
-
财政年份:1999
-
负责人:JOHN J REINERS
-
依托单位:
Novel Functions of the Ah Receptor
-
批准号:6708935
-
项目类别:
-
资助金额:$29.8万
-
财政年份:1999
-
负责人:JOHN J REINERS
-
依托单位:
Novel Functions of the Ah Receptor
-
批准号:6624514
-
项目类别:
-
资助金额:$29.8万
-
财政年份:1999
-
负责人:JOHN J REINERS
-
依托单位:
RESEARCH CORE-- SIGNAL TRANSDUCTION
-
批准号:6106371
-
项目类别:
-
资助金额:$15.83万
-
财政年份:1999
-
负责人:JOHN J REINERS
-
依托单位:
NOVEL FUNCTIONS OF THE AH RECEPTOR
-
批准号:6150734
-
项目类别:
-
资助金额:$24.99万
-
财政年份:1999
-
负责人:JOHN J REINERS
-
依托单位:
Novel Functions of the Ah Receptor
-
批准号:6475452
-
项目类别:
-
资助金额:$29.8万
-
财政年份:1999
-
负责人:JOHN J REINERS
-
依托单位:
RESEARCH CORE-- SIGNAL TRANSDUCTION
-
批准号:6271238
-
项目类别:
-
资助金额:$10.78万
-
财政年份:1998
-
负责人:JOHN J REINERS
-
依托单位:
RESEARCH CORE-- SIGNAL TRANSDUCTION
-
批准号:6239657
-
项目类别:
-
资助金额:$12.03万
-
财政年份:1997
-
负责人:JOHN J REINERS
-
依托单位:
国内基金
海外基金
登录
查看更多内容
Epac1/2通过蛋白酶体调控中性粒细胞NETosis和Apoptosis在急性肺损伤中的作用研究
-
批准号:LBY21H010001
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2020
-
负责人:郑绪阳
-
依托单位:
去乙酰化酶SIRT1在前体mRNA可变剪切中的作用及其生理病理效应研究
-
批准号:31970691
-
项目类别:面上项目
-
资助金额:58.0万元
-
批准年份:2019
-
负责人:张胜萍
-
依托单位:
TM9SF4调控非小细胞肺癌细胞凋亡机制研究
-
批准号:31900527
-
项目类别:青年科学基金项目
-
资助金额:24.0万元
-
批准年份:2019
-
负责人:孙磊
-
依托单位:
基于Apoptosis/Ferroptosis双重激活效应的天然产物AlbiziabiosideA的抗肿瘤作用机制研究及其结构改造
-
批准号:81703335
-
项目类别:青年科学基金项目
-
资助金额:20.0万元
-
批准年份:2017
-
负责人:卫高菲
-
依托单位:
双肝移植后Apoptosis和pyroptosis在移植物萎缩差异中的作用和供受者免疫微环境变化研究
-
批准号:81670594
-
项目类别:面上项目
-
资助金额:58.0万元
-
批准年份:2016
-
负责人:陈昊
-
依托单位:
Serp-2 调控apoptosis和pyroptosis 对肝脏缺血再灌注损伤的保护作用研究
-
批准号:81470791
-
项目类别:面上项目
-
资助金额:73.0万元
-
批准年份:2014
-
负责人:董家鸿
-
依托单位:
Apoptosis signal-regulating kinase 1是七氟烷抑制小胶质细胞活化的关键分子靶点?
-
批准号:81301123
-
项目类别:青年科学基金项目
-
资助金额:23.0万元
-
批准年份:2013
-
负责人:王海莲
-
依托单位:
姜黄素与TRAIL的协同抗肿瘤机制研究
-
批准号:31101223
-
项目类别:青年科学基金项目
-
资助金额:24.0万元
-
批准年份:2011
-
负责人:曹林
-
依托单位:
转凝蛋白通过线粒体凋亡途径致足细胞凋亡的机制研究
-
批准号:81100502
-
项目类别:青年科学基金项目
-
资助金额:23.0万元
-
批准年份:2011
-
负责人:管娜
-
依托单位:
APO-miR(multi-targeting apoptosis-regulatory miRNA)在前列腺癌中的表达和作用
-
批准号:81101529
-
项目类别:青年科学基金项目
-
资助金额:22.0万元
-
批准年份:2011
-
负责人:陈雪芹
-
依托单位: